» Articles » PMID: 27489079

Oxidative Stress Status in Chinese Women with Different Clinical Phenotypes of Polycystic Ovary Syndrome

Overview
Specialty Endocrinology
Date 2016 Aug 5
PMID 27489079
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine oxidative stress status and its association with clinical and metabolic parameters in Chinese women with different clinical phenotypes of polycystic ovary syndrome (PCOS).

Design: A cross-sectional study.

Patients: A total of 544 patients with PCOS and 468 control women were included.

Measurements: The total oxidant status (TOS) was determined using a microplate colorimetric method. Total antioxidant capacity (T-AOC), oxidative stress index (OSI, the ratios of TOS to T-AOC) and clinical, hormonal and metabolic parameters were also analysed.

Results: TOS and OSI were significantly higher in each of the four PCOS phenotypes based on the Rotterdam criteria than in the control women and higher in patients with hyperandrogenism (HA) than in those without HA (P < 0·05). TOS, T-AOC and OSI were higher in lean patients than in lean controls (P < 0·05). These values, except OSI, were also higher in overweight/obese patients than in lean patients, and lean or overweight/obese controls (P < 0·05). Multivariate regression analysis demonstrated that apolipoprotein (apo)A1, the Ferriman-Gallwey score, triglyceride (TG), oestradiol (E ), high-density lipoprotein cholesterol (HDL-C) and 2-h glucose levels were the main predictors of TOS; the Ferriman-Gallwey score, E , apoA1, TG and HDL-C levels were the main predictors of OSI.

Conclusions: Patients with PCOS with HA have higher oxidative stress levels compared with those without HA. The increased oxidative stress in PCOS is related to HA status, increased plasma glucose, TG, HDL-C and E levels, decreased apoA1 concentrations and a relative shortage of antioxidant capacity.

Citing Articles

Reduced low-density lipoprotein cholesterol levels are associated with increased risk of gestational diabetes mellitus in Chinese women.

Zeng S, Liu Q, Wu Y, Bai H, Fan P, Liu X Sci Rep. 2025; 15(1):6435.

PMID: 39984726 PMC: 11845585. DOI: 10.1038/s41598-025-91258-8.


Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies.

Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J Reprod Biol Endocrinol. 2024; 22(1):159.

PMID: 39722030 PMC: 11670460. DOI: 10.1186/s12958-024-01337-0.


ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.

Vaiarelli A, Cimadomo D, Rucci C, Innocenti F, Taggi M, Pittana E J Assist Reprod Genet. 2024; 41(12):3423-3432.

PMID: 39495342 PMC: 11707217. DOI: 10.1007/s10815-024-03299-z.


CTBP1 links metabolic syndrome to polycystic ovary syndrome through interruption of aromatase and SREBP1.

Kong Y, Yang G, Feng X, Ji Z, Wang X, Shao Y Commun Biol. 2024; 7(1):1174.

PMID: 39294274 PMC: 11411056. DOI: 10.1038/s42003-024-06857-4.


Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome.

Sen B, Gonultas S, Albayrak C, Temur S, Acar I, Ozkan B Obstet Gynecol Sci. 2024; 67(4):414-420.

PMID: 38757191 PMC: 11266846. DOI: 10.5468/ogs.24031.